Literature DB >> 11129295

Evidence for progression of brain structural abnormalities in schizophrenia: beyond the neurodevelopmental model.

D Velakoulis1, S J Wood, P D McGorry, C Pantelis.   

Abstract

OBJECTIVE: Clinical, neuroimaging, neuropathological and neuropsychological evidence suggests that, in schizophrenia, there is structural and functional disturbance of the hippocampus. The purpose of this paper is to present published findings concerning the nature, timing and course of these putative disturbances of hippocampal function and the pathophysiological mechanisms involved, and to explore whether schizophrenia is a disorder of neurodevelopment, neurodegeneration or a combination of both processes.
METHOD: The available cross-sectional and longitudinal evidence for hippocampal involvement in schizophrenia is reviewed and a model of hippocampal involvement in this disorder, which derives from our own cross-sectional and longitudinal hippocampal imaging data, is described.
RESULTS: We propose a three-hit model in which an early neurodevelopmental lesion renders the hippocampus vulnerable to further insult later in life during the transition phase to active illness. The available evidence suggests that the left hippocampus is particularly vulnerable during these early stages, while further insult involving the hippocampus bilaterally occurs in those who develop a chronic form of the illness.
CONCLUSIONS: Intervention strategies should target the most vulnerable stages of the illness, in particular the transition phase to psychosis, when novel treatments may prevent the illness or ameliorate its effects.

Entities:  

Mesh:

Year:  2000        PMID: 11129295     DOI: 10.1080/000486700231

Source DB:  PubMed          Journal:  Aust N Z J Psychiatry        ISSN: 0004-8674            Impact factor:   5.744


  11 in total

1.  Psychotic manifestations in brain tumour patients: 2 case reports from South Africa.

Authors:  J R Ouma
Journal:  Afr Health Sci       Date:  2004-12       Impact factor: 0.927

2.  Relapse duration, treatment intensity, and brain tissue loss in schizophrenia: a prospective longitudinal MRI study.

Authors:  Nancy C Andreasen; Dawei Liu; Steven Ziebell; Anvi Vora; Beng-Choon Ho
Journal:  Am J Psychiatry       Date:  2013-06       Impact factor: 18.112

Review 3.  Mismatch Negativity in First-Episode Schizophrenia: A Meta-Analysis.

Authors:  Sarah M Haigh; Brian A Coffman; Dean F Salisbury
Journal:  Clin EEG Neurosci       Date:  2016-05-11       Impact factor: 1.843

4.  Paternal age and schizophrenia: a population based cohort study.

Authors:  Attila Sipos; Finn Rasmussen; Glynn Harrison; Per Tynelius; Glyn Lewis; David A Leon; David Gunnell
Journal:  BMJ       Date:  2004-10-22

5.  Early psychosis research at Orygen, The National Centre of Excellence in Youth Mental Health.

Authors:  S M Cotton; K M Filia; A Ratheesh; K Pennell; S Goldstone; P D McGorry
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2016-01       Impact factor: 4.328

6.  N-acetyl cysteine reverses bio-behavioural changes induced by prenatal inflammation, adolescent methamphetamine exposure and combined challenges.

Authors:  Twanette Swanepoel; Marisa Möller; Brian Herbert Harvey
Journal:  Psychopharmacology (Berl)       Date:  2017-11-08       Impact factor: 4.530

Review 7.  Prenatal exposure to infection: a primary mechanism for abnormal dopaminergic development in schizophrenia.

Authors:  Urs Meyer; Joram Feldon
Journal:  Psychopharmacology (Berl)       Date:  2009-03-11       Impact factor: 4.530

8.  Untreated illness duration correlates with gray matter loss in first-episode psychoses.

Authors:  Srihari S Bangalore; Dhruman D Goradia; Jeffrey Nutche; Vaibhav A Diwadkar; Konasale M R Prasad; Matcheri S Keshavan
Journal:  Neuroreport       Date:  2009-05-06       Impact factor: 1.837

Review 9.  A review of vulnerability and risks for schizophrenia: Beyond the two hit hypothesis.

Authors:  Justin Davis; Harris Eyre; Felice N Jacka; Seetal Dodd; Olivia Dean; Sarah McEwen; Monojit Debnath; John McGrath; Michael Maes; Paul Amminger; Patrick D McGorry; Christos Pantelis; Michael Berk
Journal:  Neurosci Biobehav Rev       Date:  2016-04-09       Impact factor: 8.989

10.  Hippocampal shape and volume changes with antipsychotics in early stage psychotic illness.

Authors:  Daniel Mamah; Michael P Harms; Deanna Barch; Martin Styner; Jeffrey A Lieberman; Lei Wang
Journal:  Front Psychiatry       Date:  2012-11-12       Impact factor: 4.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.